CPIM
BLUE

Columbia Partners Investment Management’s bluebird bio BLUE Stock Holding History

Columbia Partners Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,313
Closed -$1.27M – 339
2016
Q1 		$1.27M Sell
2,313
-29
-1% -$17.8K 0.09% 228
2015
Q4 		$1.95M Buy
+2,342
New +$2.34M 0.13% 185

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Columbia Partners Investment Management's BLUE Position: Q2 2016 in Review

Columbia Partners Investment Management sold out of bluebird bio (BLUE) in Q2 2016, closing a stake of 2,313 shares — an estimated $1.27M sold.

Columbia Partners Investment Management first reported a position in BLUE in Q4 2015 and held it in 2 quarters. The position peaked at $1.95M in Q4 2015. 177 funds tracked by Wall St. Rank hold BLUE as of Q2 2016.

  • Columbia Partners Investment Management reported no remaining bluebird bio position as of Q2 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 2,313 bluebird bio shares in Q2 2016, an estimated $1.27M.
  • Columbia Partners Investment Management first reported a position in bluebird bio in Q4 2015 and held it in 2 quarters.
  • Columbia Partners Investment Management's bluebird bio position peaked at $1.95M in Q4 2015.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q2 2016.

Based on Columbia Partners Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.